Press Releases

SAN DIEGO, Nov. 6, 2019 /PRNewswire/ -- Trovagene, Inc. (Nasdaq: TROV), a clinical-stage, Precision Cancer Medicine™ oncology therapeutics company developing drugs that target cell division (mitosis), for the treatment of various cancers including leukemia, prostate and colorectal, today announced that data from its completed Phase

INDIANAPOLIS, Nov. 6, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that multiple abstracts from its LOXO-305 program have been accepted for presentation at the 61st American Society of Hematology Annual Meeting and Exposition to be held December 7-10, 2019 in Orlando, Florida. LOXO-3

ROCK HILL, S.C., Nov. 6, 2019 /PRNewswire/ -- Today, 3

ORLANDO, Fla., Nov. 6, 2019 /PRNewswire/ -- AllianceRx Walgreens Prime and Duquesne University School of Pharmacy recently announced results from research analyzing data from cystic fibrosis (CF) patients prescribed cystic fibrosis transmembrane conductance regulator (CFTR) modulator medications. Researchers wanted to understand if p

FAIR OAKS, Calif., Nov. 6, 2019 /PRNewswire/ -- Rick Braun is a musician, record producer and father of Emma, his 19-year-old daughter with autism. Braun's signature events raise funds for a variety of autism related causes through his immense fan base. This year's recipient, Meristem, holds a special place for the Brauns; Emma is a student

PARSIPPANY, N.J., Nov. 6, 2019 /PRNewswire/ -- Enfamil®, the #1 Pediatrician recommended infant formula brand, wants all babies to get DHA, an important nutrient, in an expert-recommended amount and as present in the worldwide breast milk average (0.32% of total fatty acids), no matter what brand their parents choose. That's why Enfamil is launching a nati

PORTLAND, Ore., Nov. 6, 2019 /PRNewswire/ -- ORM Fertility has announced the launch of

SAN DIEGO, Nov. 6, 2019 /PRNewswire/ -- HCAP Partners, a California-based private equity firm and recognized impact investor, announced today its investment in TCS Healthcare Technologies, a leading developer of population health and managed care software. Terms of the investment were not disclosed. Principal Hope

REDMOND, Wash., Nov. 6, 2019 /PRNewswire/ -- Cadence Neuroscience announced today that it has secured $15 million in Series A financing. The round was led by JAZZ Venture Partners, with additional support being provided by Mayo Clinical Ventures, Mayo Benefactors Innovation Fund, and the Epilepsy Foundation of America (EFA).

MIAMI, Nov. 6, 2019 /PRNewswire/ -- This November in Miami will be one of the hottest yet as the nation's top-muscled bodybuilders, hot-bodied bikini contestants and chiseled physique competitors head to South Florida for the highest ranked and most important and significant event of the year sanction